ARCHIVES

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Study: “If Women Smoke Like Men, They Will Die Like Men”

January 25, 2013

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

Two Conflicting Studies Presented at ASCO 2013, FDA Called Upon To Sort Through The Data

June 28, 2013

Shorter, Simpler Consent Form Proposed For Phase I Trials

July 31, 2009

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

November 26, 2010

Stronger Anti-Smoking Efforts Needed For Women, SG Says.

March 30, 2001